Newsroom

Value-based care leader and CardioVascular Care Providers celebrate long-running partnership to bring payers, providers and patients together for better healthcare through prospective bundled payment model GREENWICH, Conn., May 14, 2019 /PRNewswire/ — Cedar Gate Technologies (Cedar Gate), a leading provider of high-performance technologies for value-based care, celebrates 35 years administering the first cardiovascular prospective bundled payment program for CardioVascular Care Providers (CVCP). “In 1984 world-renowned heart surgeon Dr. Denton A. Cooley founded CVCP and pioneered

Published: May 07, 2019 May 7, 2019 13:16 UTC Collective initiative empowers care teams nationwide to identify and make better care decisions for this vulnerable population, which includes babies born with neonatal abstinence syndrome SALT LAKE CITY–(BUSINESS WIRE)– Collective Medical, delivering the nation’s most effective network for care collaboration, today announced an initiative to support high-risk infants, including those struggling with neonatal abstinence syndrome (NAS). The Collective Platform now empowers care teams to quickly identify,

May 01, 2019 06:00 AM Eastern Daylight Time IRVING, Texas–(BUSINESS WIRE)–Vizient announces the expansion of its Environmentally Preferred Sourcing (EPS) program with the May 1 launch of the nation’s largest, most comprehensive portfolio of environmentally preferred furniture. This brings the total number of environmentally preferred (EP) products in the Vizient EPS program to more than 450,000 items. The companies now under contract offer furniture that is free of formaldehyde, perfluorinated compounds, polyvinyl chloride, antimicrobials and

ATLANTA, April 9, 2019 /PRNewswire/ — Jackson Healthcare®, a family of highly-specialized healthcare staffing, search and technology companies, today announced its inclusion on Fortune’s newly-published “Best Workplaces in Health Care and Biopharma” list. This is the second consecutive year that the company has made the list. Best Workplaces lists are compiled by research and consulting firm Great Place to Work and Fortune, and for this 2019 ranking, involved the analysis of input from nearly 730,000

April 09, 2019 IRVING, Texas–(BUSINESS WIRE)–Over the last six years, the U.S. Food and Drug Administration has approved a number of highly innovative medical devices that have revolutionized cardiovascular care. These novel devices have provided advanced treatment options, improved quality of life and extended longevity for patients. Unfortunately, reimbursement has often failed to keep up with many of increasingly expensive treatment options. In the report, “The cost of medical device innovation: can we keep pace?”